ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.5875
-0.0411 (-6.54%)
At close: Apr 1, 2025, 4:00 PM
0.6017
+0.0142 (2.42%)
After-hours: Apr 1, 2025, 5:51 PM EDT
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.38 million as of April 1, 2025. Its market cap has decreased by -76.77% in one year.
Market Cap
1.38M
Enterprise Value
-128.63K
1-Year Change
-76.77%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from $95.47M to $1.38M, a decrease of -98.56%. That is a compound annual growth rate of -74.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 1.38M | -44.58% |
| Dec 31, 2024 | 2.48M | -47.34% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |